TUMOUR n ecro s is fa ctor-a (TNF-a ) is a m ajor p roin flam m ato ry cytokin e in ducin g th e s yn th e s is and
Introduction
Tumour ne crosis fac tor-a (TNF-a ) is produced by many differe nt type s of c ells including activate d macrophage s and fibroblasts. It has divers e effe cts on the target c ells including inducing cytotox ic ity to L929 cells, stimulating fibroblast c ell prolife ration, and inc re asing PGE 2 and arachidonic acid production. 1 -3 TNF-a is also involve d in many immune diseases such as rheumatoid arthritis, 4 se psis, immunode fic ie nc y, 5 insulin-depe nde nt diabete s me llitus 6 and inflammation. The re gulation of TNF-a production is c ritical in the maintenanc e of homeostasis of the immune syste m and in the pre ve ntion and tre atment of the immune dise as es. Acanthoic ac id, (-)-primara-9(11), 15-dien-19-oic acid, is a diterpe ne is olated from the root bark of Aca n th o pa n a x ko re a nu m , w hich has be e n traditionally use d as a tonic and sedative as w ell as in the tre atment of rheumatism and diabete s in Kore a. 7 Previous studies 8 ,9 using this diterpe noid compound demonstrate d that it inhibited TNF-a production by human monocyte s/mac rophages and in the se ra of silicosis model. Also, its oral administration into the mic e significantly re duc ed the w rithing syndrome induc ed by ac etic ac id and it re duce d leukotriene B4 production by leukocyte s in vitro at the c oncentration of about 30 m g/ml. In this study, to analyse the effects of ac anthoic acid on TNF-a produc tion further, w e te ste d it on TNF-a gene ex pre ssion and haptoglobin production re gulated by TNF-a .
Materials and Methods

Preparation of acanthoic acid
Acanthoic ac id w as is olated e sse ntially as de scribe d pre viously. 7 Usually, more than 95% pure ac anthoic acid w as obtaine d by fractionation on a silica-gel column chromatography (n -hex ane -ethylac etate , 20:1 to 5:1).
Isolation of human monocytes/macrophages
He parinized blood obtained from healthy donors w as overlayere d on a Ficoll-Hypaque de nsity gradient and ce ntrifuge d at 700 3 g for 30 min. Mononucle ar c ells and ne utrophils w e re obtained at the dens ity of 1.077 g/l and of 1.077-1.119 g/l re spec tively. Mononuclear ce lls w ere incubated in a 24-w ell culture plate for 2 h and adhere nt monocyte s/mac rophages (> 90% purity by non-specific e ste rase staining) w ere obtain ed. Then the ce lls w ere pre incubated w ith various conce ntration s of acanthoic ac id for 1 h and stimulated w ith 100 m g/ml silic a. After 48 h inc ubation, the culture supernatants w ere assayed for TNF-a using a TNF-a ELISA kit obtaine d from Ge nzyme (Cambridge, MA).
Transfection of TNF-a CAT construct
He La c ells (5 3 10 5 ce lls/sample) w ere transfe cte d w ith 10 m g TNF-a promoter-CAT re porter plasmid using c alcium-phosphate method. Afte r 16 h inc ubation, c ells w ere treated w ith 10 m g/ml LPS plus 100 ng/ml PMA for 18 h in the pre se nce or absenc e of acanthoic ac id. Then 10 m g of cell lysate s w ere assaye d for CAT activity. The CAT ac tivity w as calculated as follow s: acetylation rate = (c pm in acetylate d spe cie s/c pm in ace tylated sp ecie s + nonacetylate d chloramphenic ol).
Results and Discussion
Previous re sults show ed that ac anthoic acid inhibite d TNF-a produc tion from human monocyte s/mac rophage s stimulated w ith 100 m g/ml silica. Se veral diterp ene compounds having similar structure s is olated from the root bark of Aca n th o p a n a x ko re a n u m w ere te ste d for inhibitin g TNF-a synthesis. Ac anthoic acid significantly inhibited TNF-a produc tion from human monocyte s/mac rophages (73.4± 7.9% inhibition c ompared w ith untre ated control), but other diterp ene s had no e ffec ts on TNF-a production (data not show n). It also suppre ssed TNF-a produc tion in the se ra of ex perime ntal silicosis rats (79.5± 1.4% inhibition c ompared w ith untreated silicosis rats).
To know the molec ular ac tion of acanthoic acid on TNF-a synthe sis, the e ffec ts of acanthoic ac id on TNFa ge ne ex pre ssion w ere te ste d. Acanthoic ac id suppre ssed PWM-induce d TNF-a ge ne ex pre ssion in human monoc ytes/macrophages (Fig. 1A) . But it had no effects on the ge ne ex pre ssion of IL-6 and b -ac tin. Furthe rmore , acanthoic acid suppre ssed the promote r activity of TNF-a ac tivated w ith LPS and PMA (Fig. 1B,C) . 10 m g/ml acanthoic ac id inhibited about 50% of LPS and PMA-induced TNF-a promote r activ ity.
TNF-a is involved in hepatic inflammation and fibrosis . In the liver, TNF-a induce s a group of ac ute phase prote ins including haptogloin. 10 Haptoglobin is re lated to the status of inflammation, infe ction and malignancy.
11 -1 3 So w e te ste d the effe cts of acanthoic ac id on haptoglobin synthe sis of hepatocyte s. TNF-a inhibited hap toglobin synthesis of He p3B c ells stimulated w ith LPS and PMA (Fig. 2) , but it had no effects on He p3B c ell prolife ration (data not show n).
Acanthoic acid is a dite rpene is olated from Aca nth o pa n a x ko re a n u m . It has anti-inflammatory e ffec ts in vivo and in v itro . In this study, it is demonstrate d 5 cells/sample) were transfected with 10 m g TNF-a promoter-CAT reporter plasmid using calciumphosphate method. After 16h incubation, cells were treated with 10m g/ml LPS plus 100ng/ml PMA for 18 h in the presence or absence of acanthoic acid. Then 10m g of cell lysates were assayed for CAT activity. (C) The CAT activity was calculated as follows: % acetylation = (cpm in acetylated species/cpm in acetylated species + non-acetylated chloramphenicol) 3 100.
that the main intrac ellular target of acanthoic acid is machinery of TNF-a ge ne ex pre ssion. The ex act targe t molecule w hich interac ts w ith acanthoic acid ne eds to be de fine d. Cons idering its action of me chnism, it w ill be use d as an anti-inflammatory agent to treat many inflammatory diseases. The cells were preincubated with 10m g/ml acanthoi c acid for 1h and stimulated with 10m g/ml LPS and/or 100ng/ml PMA. After 48 h incubation, the culture supernatants were assayed for haptoglobin production using haptoglobin ELISA. Data represent the mean ± SD of four different determinants.
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